๊ฑฐ๋ž˜์†Œ
์ค‘์•™ํ™” ๊ฑฐ๋ž˜์†Œ
ํƒˆ์ค‘์•™ํ™” ๊ฑฐ๋ž˜์†Œ

Moderna Inc ์ฃผ๊ฐ€
MRNA
#534

โ‚ฉ91,625.45
ย ย 

2.1%

Moderna Inc Info

์‹œ๊ฐ€์ด์•ก
โ‚ฉ36.35T

2.1%

์ผ๊ฐ„ ๊ฑฐ๋ž˜๋Ÿ‰
โ‚ฉ358.26B
์›น์‚ฌ์ดํŠธ
์ž์‚ฐ ์œ ํ˜•
Stock
์ง์›
5800
์„ค๋ฆฝ
Sep 1, 2010
์ฃผ ๊ฑฐ๋ž˜์†Œ
Nasdaq
์‚ฐ์—…
Biological Products, (No Diagnostic Substances)
CIK ๋ฒˆํ˜ธ
0001682852

ํ† ํฐํ™”๋œ ์ฃผ์‹ ๋ฐ์ดํ„ฐ

ํ‰๊ท  ํ† ํฐํ™”๋œ ๊ฐ€๊ฒฉ
โ‚ฉ90.83K
๊ฐ€๊ฒฉ ์ฐจ์ด
+โ‚ฉ786.09(-0.86%)
ํ† ํฐํ™”๋œ ์‹œ์ด
โ‚ฉ84.69M

0.01%

ํ† ํฐํ™”๋œ ๊ฑฐ๋ž˜๋Ÿ‰(24์‹œ๊ฐ„)
โ‚ฉ889.57M

0.71%

๋ฐœํ–‰์ธ
๊ณ„์•ฝ
์ต์Šคํ”Œ๋กœ๋Ÿฌ
MRNA USD ๋ณ€ํ™˜๊ธฐ
MRNA
KRW
๊ฐ€๊ฒฉ ํผํฌ๋จผ์Šค
๋‚ฎ์Œ
โ‚ฉ90.41K
๋†’์Œ
โ‚ฉ93.7K

๋ฐ์ดํ„ฐ ๋กœ๋”ฉ ์ค‘

์ž ์‹œ๋งŒ ๊ธฐ๋‹ค๋ ค ์ฃผ์„ธ์š”, ์ฐจํŠธ ๋ฐ์ดํ„ฐ๋ฅผ ๋กœ๋”ฉํ•˜๊ณ  ์žˆ์Šต๋‹ˆ๋‹ค

Moderna Inc ์ปค๋ฎค๋‹ˆํ‹ฐ

skeleton-white
ย 
ย 
ย 
ย 
ย 
ย 

About Moderna Inc

What is Moderna Inc?

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna Inc ๋ผ์ด๋ธŒ ๊ฐ€๊ฒฉ ๋ฐ์ดํ„ฐ

The current price of Moderna Inc in the market is โ‚ฉ91,625.45, with a 24-hour trading volume of โ‚ฉ358.26B. The asset's market cap is โ‚ฉ36.35T, after moving -2.11% in the last day.

Tokenized Moderna Inc is trading at โ‚ฉ90,839.36, with a tokenized market cap of โ‚ฉ84.69M and a 24-hour trading volume of โ‚ฉ889.57M. The tokenized asset has moved -0.02% in the past 24 hours.